Programmed death-1 shapes memory phenotype CD8 T cell subsets in a cell-intrinsic manner

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6104-6114

  Charlton, Joanna J ^a,b   Chatzidakis, Ioannis ^a,b   Tsoukatou, Debbie ^a   Boumpas, Dimitrios T ^a,b   Garinis, George A ^a,c   Mamalaki, Clio ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL ESTER;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTOPENIA; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTE SUBSETS;

EID: 84879125380     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201617     Document Type: Article

References (60)

1. Sprent, J., and C. D. Surh. 2011. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat. Immunol. 12: 478-484.
2. + T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J. Exp. Med. 206: 435-448.
3. + T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 198: 1583-1593.
4. + T cells provide an early source of IFN-γ. J. Immunol. 170: 2399-2408.
5. Lanzavecchia, A., and F. Sallusto. 2005. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17: 326-332. (Pubitemid 40692670)
6. + T cells and their conversion to memory T cells. Immunol. Rev. 236: 151-166.
7. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrançois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417. (Pubitemid 32231804)
8. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
9. Sarkar, S., V. Teichgräber, V. Kalia, A. Polley, D. Masopust, L. E. Harrington, R. Ahmed, and E. J. Wherry. 2007. Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation. J. Immunol. 179: 6704-6714.
10. Wherry, E. J., V. Teichgräber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234. (Pubitemid 36322131)
11. Bouneaud, C., Z. Garcia, P. Kourilsky, and C. Pannetier. 2005. Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo. J. Exp. Med. 201: 579-590. (Pubitemid 40289548)
12. Huster, K. M., M. Koffler, C. Stemberger, M. Schiemann, H. Wagner, and D. H. Busch. 2006. Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells. Eur. J. Immunol. 36: 1453-1464. (Pubitemid 43942135)
13. Marzo, A. L., H. Yagita, and L. Lefrançois. 2007. Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cells. J. Immunol. 179: 36-40. (Pubitemid 46986514)
14. + T cell differentiation. J. Exp. Med. 207: 1235-1246.
15. + T cell precursor can develop into diverse effector and memory subsets. Immunity 27: 985-997.
16. Burmeister, Y., T. Lischke, A. C. Dahler, H. W. Mages, K. P. Lam, A. J. Coyle, R. A. Kroczek, and A. Hutloff. 2008. ICOS controls the pool size of effectormemory and regulatory T cells. J. Immunol. 180: 774-782.
17. + T cell responses in aged mice through blockade of an immunoinhibitory pathway. J. Immunol. 184: 5475-5484.
18. + memory T cells and their capacity for secondary expansion. J. Immunol. 175: 1665-1676.
19. + T cell-intrinsic homeostasis and memory cell generation. Nat. Immunol. 8: 162-171.
20. Mousavi, S. F., P. Soroosh, T. Takahashi, Y. Yoshikai, H. Shen, L. Lefrançois, J. Borst, K. Sugamura, and N. Ishii. 2008. OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells. J. Immunol. 181: 5990-6001.
21. + T cells. J. Immunol. 179: 5014-5023.
22. Takahashi, N., K. Matsumoto, H. Saito, T. Nanki, N. Miyasaka, T. Kobata, M. Azuma, S. K. Lee, S. Mizutani, and T. Morio. 2009. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients. J. Immunol. 182: 5515-5527.
23. Francisco, L. M., P. T. Sage, and A. H. Sharpe. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236: 219-242.
24. Okazaki, T., and T. Honjo. 2007. PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 19: 813-824. (Pubitemid 47241890)
25. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687. (Pubitemid 43237609)
26. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354. (Pubitemid 44435155)
27. Brown, K. E., G. J. Freeman, E. J.Wherry, and A. H. Sharpe. 2010. Role of PD-1 in regulating acute infections. Curr. Opin. Immunol. 22: 397-401.
28. Lages, C. S., I. Lewkowich, A. Sproles, M. Wills-Karp, and C. Chougnet. 2010. Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/PD-L1 pathway. Aging Cell 9: 785-798.
29. + T cells as regulatory versus memory T cells. J. Immunol. 185: 803-807.
30. Lin, S. J., C. D. Peacock, K. Bahl, and R. M. Welsh. 2007. Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation. J. Exp. Med. 204: 2321-2333. (Pubitemid 47529319)
31. Nishimura, H., N. Minato, T. Nakano, and T. Honjo. 1998. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10: 1563-1572. (Pubitemid 28451451)
32. de Boer, J., A. Williams, G. Skavdis, N. Harker, M. Coles, M. Tolaini, T. Norton, K. Williams, K. Roderick, A. J. Potocnik, and D. Kioussis. 2003. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33: 314-325. (Pubitemid 36267595)
33. Veiga-Fernandes, H., M. C. Coles, K. E. Foster, A. Patel, A. Williams, D. Natarajan, A. Barlow, V. Pachnis, and D. Kioussis. 2007. Tyrosine kinase receptor RET is a key regulator of Peyer's patch organogenesis. Nature 446: 547-551. (Pubitemid 46514720)
34. Chatzidakis, I., G. Fousteri, D. Tsoukatou, G. Kollias, and C. Mamalaki. 2007. An essential role for TNF in modulating thresholds for survival, activation, and tolerance of CD8+ T cells. J. Immunol. 178: 6735-6745. (Pubitemid 46847397)
35. + T cell lineage commitment. Nat. Immunol. 6: 793-799.
36. Venturi, G. M., L. Tu, T. Kadono, A. I. Khan, Y. Fujimoto, P. Oshel, C. B. Bock, A. S. Miller, R. M. Albrecht, P. Kubes, et al. 2003. Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity 19: 713-724. (Pubitemid 37490796)
37. Boyman, O., S. Létourneau, C. Krieg, and J. Sprent. 2009. Homeostatic proliferation and survival of naïve and memory T cells. Eur. J. Immunol. 39: 2088-2094.
38. Daniels, M. A., and E. Teixeiro. 2010. The persistence of T cell memory. Cell. Mol. Life Sci. 67: 2863-2878.
39. Hamilton, S. E., M. C. Wolkers, S. P. Schoenberger, and S. C. Jameson. 2006. The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat. Immunol. 7: 475-481.
40. Funatake, C. J., K. Ao, T. Suzuki, H. Murai, M. Yamamoto, Y. Fujii-Kuriyama, N. I. Kerkvliet, and K. Nohara. 2009. Expression of constitutively-active aryl hydrocarbon receptor in T-cells enhances the down-regulation of CD62L, but does not alter expression of CD25 or suppress the allogeneic CTL response. J. Immunotoxicol. 6: 194-203.
41. Lawrence, B. P., and B. A. Vorderstrasse. 2004. Activation of the aryl hydrocarbon receptor diminishes the memory response to homotypic influenza virus infection but does not impair host resistance. Toxicol. Sci. 79: 304-314. (Pubitemid 38786888)
42. Miyazaki, K., M. Miyazaki, Y. Guo, N. Yamasaki, M. Kanno, Z. Honda, H. Oda, H. Kawamoto, and H. Honda. 2010. The role of the basic helix-loop-helix transcription factor Dec1 in the regulatory T cells. J. Immunol. 185: 7330-7339.
43. Agarwal, P., A. Raghavan, S. L. Nandiwada, J. M. Curtsinger, P. R. Bohjanen, D. L. Mueller, and M. F. Mescher. 2009. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J. Immunol. 183: 1695-1704.
44. Ju, S., Y. Zhu, L. Liu, S. Dai, C. Li, E. Chen, Y. He, X. Zhang, and B. Lu. 2009. Gadd45b and Gadd45g are important for anti-tumor immune responses. Eur. J. Immunol. 39: 3010-3018.
45. Valenzuela, J. O., C. D. Hammerbeck, and M. F. Mescher. 2005. Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells. J. Immunol. 174: 600-604. (Pubitemid 40094249)
46. Huster, K. M., V. Busch, M. Schiemann, K. Linkemann, K. M. Kerksiek, H. Wagner, and D. H. Busch. 2004. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc. Natl. Acad. Sci. USA 101: 5610-5615. (Pubitemid 38481204)
47. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198. (Pubitemid 37540688)
48. Allie, S. R., W. Zhang, S. Fuse, and E. J. Usherwood. 2011. Programmed death 1 regulates development of central memory CD8 T cells after acute viral infection. J. Immunol. 186: 6280-6286.
49. Laouar, A., M. Manocha, V. Haridas, and N. Manjunath. 2008. Concurrent generation of effector and central memory CD8 T cells during vaccinia virus infection. PLoS ONE 3: e4089.
50. Amanna, I. J., M. K. Slifka, and S. Crotty. 2006. Immunity and immunological memory following smallpox vaccination. Immunol. Rev. 211: 320-337. (Pubitemid 43882983)
51. Hansen, S. G., J. C. Ford, M. S. Lewis, A. B. Ventura, C. M. Hughes, L. Coyne-Johnson, N. Whizin, K. Oswald, R. Shoemaker, T. Swanson, et al. 2011. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473: 523-527.
52. Vezys, V., A. Yates, K. A. Casey, G. Lanier, R. Ahmed, R. Antia, and D. Masopust. 2009. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457: 196-199.
53. + T cell differentiation. Immunity 33: 128-140.
54. Grosso, J. F., M. V. Goldberg, D. Getnet, T. C. Bruno, H. R. Yen, K. J. Pyle, E. Hipkiss, D. A. Vignali, D. M. Pardoll, and C. G. Drake. 2009. Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. J. Immunol. 182: 6659-6669.
55. + T cell exhaustion during chronic viral infection. Immunity 27: 670-684.
56. + T cells in lymphopenic hosts. Immunity 11: 183-190.
57. Thangavelu, G., J. C. Parkman, C. L. Ewen, R. R. Uwiera, T. A. Baldwin, and C. C. Anderson. 2011. Programmed death-1 is required for systemic self-tolerance in newly generated T cells during the establishment of immune homeostasis. J. Autoimmun. 36: 301-312.
58. Boyman, O., J. H. Cho, J. T. Tan, C. D. Surh, and J. Sprent. 2006. A major histocompatibility complex class I-dependent subset of memory phenotype CD8+ cells. J. Exp. Med. 203: 1817-1825. (Pubitemid 44036286)
59. Brahmer, J. R., C. G. Drake, I. Wollner, J. D. Powderly, J. Picus, W. H. Sharfman, E. Stankevich, A. Pons, T. M. Salay, T. L. McMiller, et al. 2010. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol. 28: 3167-3175.
60. + T cell immunity. J. Transl. Med. 8: 132.